J. L. Schelling

583 total citations
16 papers, 426 citations indexed

About

J. L. Schelling is a scholar working on Pharmacology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. L. Schelling has authored 16 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. L. Schelling's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). J. L. Schelling is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). J. L. Schelling collaborates with scholars based in Switzerland, United States and France. J. L. Schelling's co-authors include Louis Lasagna, Jean-Pierre Berger, Eileen M. Brooke, Léon Tétreault, Philippe Leuenberger, A. Dettling, Daphne Weihs, B Scazziga, Neda Milinković and Flavio Villani and has published in prestigious journals such as The Lancet, Stroke and Clinical Pharmacology & Therapeutics.

In The Last Decade

J. L. Schelling

16 papers receiving 366 citations

Peers

J. L. Schelling
J. L. Schelling
Citations per year, relative to J. L. Schelling J. L. Schelling (= 1×) peers Mark L. Wahlqvist

Countries citing papers authored by J. L. Schelling

Since Specialization
Citations

This map shows the geographic impact of J. L. Schelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Schelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Schelling more than expected).

Fields of papers citing papers by J. L. Schelling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Schelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Schelling. The network helps show where J. L. Schelling may publish in the future.

Co-authorship network of co-authors of J. L. Schelling

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Schelling. A scholar is included among the top collaborators of J. L. Schelling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Schelling. J. L. Schelling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Buclin, Thierry, Jérôme Biollaz, Erik A. Lippa, et al.. (1991). Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects. Clinical Pharmacology & Therapeutics. 49(6). 665–673. 11 indexed citations
2.
3.
Schelling, J. L.. (1985). [Psychotropic agents in elderly persons].. PubMed. 115(50). 1808–14. 1 indexed citations
4.
Jaeger, P, et al.. (1981). Immersion and Venous Occlusion Plethysmography in Patients with Idiopathic Orthostatic Hypotension. PubMed. 3(5). 919–927. 4 indexed citations
5.
Leuenberger, Philippe, et al.. (1979). Judgments of trained observers on adverse drug reactions. Clinical Pharmacology & Therapeutics. 25(5part1). 493–498. 59 indexed citations
6.
Berger, Jean-Pierre, et al.. (1978). Intravenous glycerol in cerebral infarction: a controlled 4-month trial.. Stroke. 9(5). 484–486. 27 indexed citations
7.
Dettling, A., et al.. (1978). Effect of the menstrual cycle, oral contraception and pregnancy on forearm blood flow, venous distensibility and clotting factors. European Journal of Clinical Pharmacology. 13(4). 251–257. 39 indexed citations
8.
Schelling, J. L., et al.. (1976). Effect of paracetamol, mephenoxalone and their combination on pain following bone surgery. European Journal of Clinical Pharmacology. 9(5-6). 411–415. 7 indexed citations
9.
Schelling, J. L., et al.. (1975). Effect of foodstuffs on the absorption of zinc sulfate. Clinical Pharmacology & Therapeutics. 17(4). 469–474. 111 indexed citations
10.
Villani, Flavio, et al.. (1974). Effect of phentolamine on peripheral venous distensibility in congestive heart failure. European Journal of Clinical Pharmacology. 7(1). 11–16. 8 indexed citations
11.
Schelling, J. L., et al.. (1973). Effect of pindolol, a beta receptor antagonist, in hyperthyroidism. Clinical Pharmacology & Therapeutics. 14(2). 158–164. 13 indexed citations
12.
Schelling, J. L.. (1973). EFFECT OF FOOD ON ZINC ABSORPTION. The Lancet. 302(7835). 968–969. 14 indexed citations
13.
Peters, G., Jean‐Philippe Bonjour, J.-P. Guignard, et al.. (1972). General and renal toxicity of phenacetin, paracetamol and some anti-mitotic agents in the rat. Archives of Toxicology. 28(4). 225–269. 10 indexed citations
14.
Schelling, J. L.. (1969). Acute effect of some combinations of analgesic and non-analgesic drugs in cancer patients. European Journal of Clinical Pharmacology. 2(1). 19–22. 1 indexed citations
15.
Schelling, J. L. & Louis Lasagna. (1967). A study of cross‐tolerance to circulatory effects of organic nitrates. Clinical Pharmacology & Therapeutics. 8(2). 256–260. 68 indexed citations
16.
Schelling, J. L., et al.. (1965). ABNORMAL TASTE THRESHOLD IN DIABETES. The Lancet. 285(7384). 508–511. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026